251 related articles for article (PubMed ID: 7520262)
1. Vascular targeting and the inhibition of angiogenesis.
Bicknell R
Ann Oncol; 1994; 5 Suppl 4():45-50. PubMed ID: 7520262
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis.
Folkman J; Ingber D
Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314
[TBL] [Abstract][Full Text] [Related]
3. [Development of anti tumor agents targeting angiogenesis].
Ono M; Kuwano M
Gan To Kagaku Ryoho; 1997 Jan; 24(2):178-86. PubMed ID: 9030228
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and angiogenesis inhibitors in cancer.
Giavazzi R; Taraboletti G
Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
[TBL] [Abstract][Full Text] [Related]
5. Advances in understanding angiogenesis through molecular studies.
Kwon M; Libutti SK
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
[TBL] [Abstract][Full Text] [Related]
6. Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells?
Gasparini G; Harris AL
Eur J Cancer; 1994; 30A(2):201-6. PubMed ID: 7512357
[No Abstract] [Full Text] [Related]
7. Inhibition of tumor angiogenesis.
Sipos EP; Tamargo RJ; Weingart JD; Brem H
Ann N Y Acad Sci; 1994 Sep; 732():263-72. PubMed ID: 7526758
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis: possibilities for therapeutic interventions.
Wynendaele W; van Oosterom AT; Pawinski A; de Bruijn EA; Maes RA
Pharm World Sci; 1998 Dec; 20(6):225-35. PubMed ID: 9972522
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Angiogenesis agents.
Marcinkiewicz C
Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
[No Abstract] [Full Text] [Related]
10. Angiogenesis research enjoys growth spurt in the 1990s.
Ziegler J
J Natl Cancer Inst; 1996 Jun; 88(12):786-8. PubMed ID: 8637041
[No Abstract] [Full Text] [Related]
11. [Vascularization and perfusion of tumors as target in cancer therapy].
Bernsen HJ; van der Kogel AJ; van Daal WA; Rijken PF
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):364-8. PubMed ID: 9157295
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of tumor angiogenesis as a cancer treatment].
Verheul HM; Bom JB; Hoekman K; Pinedo HM
Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis at the interface between basic and clinical research.
Albini A; Noonan D; Santi L
Int J Biol Markers; 1999; 14(4):202-6. PubMed ID: 10669947
[TBL] [Abstract][Full Text] [Related]
14. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
Bahramsoltani M; Plendl J
APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.
Ranieri G; Gasparini G
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):241-53. PubMed ID: 12477290
[TBL] [Abstract][Full Text] [Related]
16. [Targeting angiogenesis in oncology].
Fayette J; Soria JC; Armand JP
Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
[TBL] [Abstract][Full Text] [Related]
17. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
18. [Angiogenesis and the regulation of antitumor defense].
Pappas NP; Hillen HF; Wagstaff J; Griffioen AW
Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1555-9. PubMed ID: 10443280
[TBL] [Abstract][Full Text] [Related]
19. Tumour vasculature as a target for anticancer therapy.
Eatock MM; Schätzlein A; Kaye SB
Cancer Treat Rev; 2000 Jun; 26(3):191-204. PubMed ID: 10814561
[TBL] [Abstract][Full Text] [Related]
20. Vascular damaging agents.
Patterson DM; Rustin GJ
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):443-56. PubMed ID: 17459681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
